| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/26/2006 | WO2006093405A3 Means and methods for producing polymers comprising peptide in a side chain |
| 10/26/2006 | WO2006077035A9 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 10/26/2006 | WO2005054427A3 Target sequences for synthetic molecules |
| 10/26/2006 | US20060241286 Novel peptides and the application thereof in therapy |
| 10/26/2006 | US20060241283 Volatilizable solid phase supports for compound synthesis |
| 10/26/2006 | US20060241281 Peptidomimetic polymers for antifouling surfaces |
| 10/26/2006 | US20060241055 Peptides promoting cell adherence, growth and secretion |
| 10/26/2006 | US20060241051 Metastin derivatives and use thereof |
| 10/26/2006 | US20060241048 Modified therapeutic agents |
| 10/26/2006 | US20060241034 Means for preventing and treating cellular death and their biological applications |
| 10/26/2006 | US20060241028 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activating peptide |
| 10/26/2006 | US20060241026 Novel cyclic peptides and use thereof as anti-microbial agents |
| 10/26/2006 | US20060241024 Intermediate for preparing glycopeptide derivatives |
| 10/26/2006 | US20060241020 Protein tyrosine phosphatase inhibitors |
| 10/26/2006 | US20060241018 Linkers for radiopharmaceutical compounds |
| 10/26/2006 | US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 10/26/2006 | US20060240477 polypeptide comprising a symmetrical dimethylated arginine, is used for diagnosing systemic lupus erythematosus |
| 10/26/2006 | US20060240475 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal |
| 10/26/2006 | US20060239913 Peptide conjugate for magnetic resonance imaging |
| 10/25/2006 | EP1715042A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRCITED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME |
| 10/25/2006 | EP1715040A2 Zinc finger binding domains for GNN |
| 10/25/2006 | EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/25/2006 | EP1714978A1 Peptides useful for diagnosis and therapy of tumors |
| 10/25/2006 | EP1714977A2 Synthesis of cyclosporin analogs |
| 10/25/2006 | EP1714976A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 10/25/2006 | EP1714975A2 Gene and peptide for transcriptional repressor |
| 10/25/2006 | EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission |
| 10/25/2006 | EP1714157A2 Method for identifying and quantifying of tumour-associated peptides |
| 10/25/2006 | EP1713723A2 Fullerene based amino acids |
| 10/25/2006 | EP1713439A1 Pharmaceutical preparation for the oral cavity |
| 10/25/2006 | EP1377275B1 Vaccine for modulating between t1 and t2 immune responses |
| 10/25/2006 | EP1373308B1 Antagonist for multimerization of hiv-1 vif protein |
| 10/25/2006 | EP1265849B1 Compounds and methods to treat alzheimer's disease |
| 10/25/2006 | EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses |
| 10/25/2006 | CN1852920A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 10/25/2006 | CN1281625C WT1 modified peptide |
| 10/25/2006 | CN1281619C Process for preparing glycopeptide derivatives |
| 10/25/2006 | CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 10/24/2006 | US7125872 protease/thrombin inhibitors |
| 10/24/2006 | US7125850 Growth Arrest and DNA Damage-inducible gene 45 (GADD45); for sensitizing proliferating cells by adminstering antibodies; liposomes |
| 10/24/2006 | US7125849 Peptide-based angiogenesis inhibitors and methods of use thereof |
| 10/24/2006 | US7125844 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 10/24/2006 | US7125842 Anti-fungal compounds and methods of use |
| 10/24/2006 | US7125838 Peptides containing N-substituted L-amino acids for preventing β-strand association |
| 10/24/2006 | US7125678 Protein biopolymer markers predictive of type II diabetes |
| 10/24/2006 | CA2273549C Diagnostic agents for pancreatic exocrine function |
| 10/19/2006 | WO2006108686A2 Bnp agonists |
| 10/19/2006 | WO2006108586A2 Polymyxin b analogs for lps detoxification |
| 10/19/2006 | WO2006108270A1 Inhibitors of protein kinases and uses thereof |
| 10/19/2006 | US20060235203 MN gene and protein |
| 10/19/2006 | US20060235199 Reagent for amplifying amyloid fibrosis of amyloid ss-protein |
| 10/19/2006 | US20060234945 Ophthalmic therapeutic composition |
| 10/19/2006 | US20060234944 Beta-secretase inhibitors and methods of use |
| 10/19/2006 | US20060234943 Biological active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
| 10/19/2006 | US20060234942 Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements |
| 10/19/2006 | US20060234941 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 10/19/2006 | US20060234940 Secondary binding site of dipeptidyl peptidase IV (DP IV) |
| 10/19/2006 | US20060234938 Amino acid sequences which target pre-B-cell transformation related gene (PBX) expression for use in treatment of cell proliferative disorders; antiproliferative agents |
| 10/19/2006 | US20060234928 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/19/2006 | US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/19/2006 | US20060234923 solid phase synthesis; solution phase synthesis; hairpin motifs; chemokine receptor 4 antagonists |
| 10/19/2006 | US20060234920 New antitumoral compounds |
| 10/19/2006 | US20060234914 Fragments of proinsulin c-peptide |
| 10/19/2006 | US20060234912 Methods for modulating neuronal responses |
| 10/19/2006 | US20060234909 Compositions and methods for increasing drug efficiency |
| 10/19/2006 | US20060234905 Method of stimulating growth and resistance to diseases of aquatic organisms |
| 10/19/2006 | US20060234314 Selective binding and analysis of macromolecules |
| 10/19/2006 | US20060234306 Assay method |
| 10/19/2006 | US20060234208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 10/19/2006 | US20060233804 IGF antagonist peptides |
| 10/19/2006 | US20060233779 Ring finger family proteins and uses related thereto |
| 10/19/2006 | US20060233742 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 10/19/2006 | US20060233704 Prochelator for the preparation of radiometal labeled molecules having improved biological properties |
| 10/19/2006 | CA2603850A1 Polymyxin b analogs for lps detoxification |
| 10/18/2006 | EP1712559A1 Polymyxin B analogs for LPS detoxification |
| 10/18/2006 | EP1711604A1 Diabetogenic epitopes |
| 10/18/2006 | EP1711515A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 10/18/2006 | EP1711483A2 A method for manufacturing optically pure coumaryl amino acid salts and the coumaryl amino acid salts thus obtained |
| 10/18/2006 | EP1465917B1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 10/18/2006 | EP1212352B1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 10/18/2006 | EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 10/18/2006 | EP0656788B1 Hla binding peptides and their uses |
| 10/18/2006 | CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin |
| 10/18/2006 | CN1849333A New antitumoral compounds |
| 10/18/2006 | CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer |
| 10/18/2006 | CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists |
| 10/18/2006 | CN1280307C Cytotoxin T lymphocyte |
| 10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
| 10/17/2006 | US7122631 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/17/2006 | US7122628 Process for the synthesis of a peptide having a Trp residue |
| 10/17/2006 | US7122625 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 10/17/2006 | US7122623 Compounds and methods for modulating cell adhesion |
| 10/17/2006 | US7122622 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis |
| 10/17/2006 | US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin |
| 10/17/2006 | US7122523 Methods for inhibiting tumor cell proliferation |
| 10/17/2006 | US7122519 Didemnin analogs and fragments and methods of making and using them |
| 10/17/2006 | US7122517 Crystallized structure of type IV collagen NC1 domain hexamer |
| 10/17/2006 | US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 10/17/2006 | US7122372 Peptide useful in immunomodulation |
| 10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |